Jacobi Capital Management’s AIM ImmunoTech AIM Stock Holding History

Jacobi Capital Management’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Hold	0	–	–	–	1469
2021 Q3	–	Hold	0	–	–	–	1525
2021 Q2	–	Hold	0	–	–	–	1460
2021 Q1	–	Hold	0	–	–	–	1494
2020 Q4	–	Hold	0	–	–	–	1419
2020 Q3	–	Hold	0	–	–	–	1343
2020 Q2	–	Hold	0	–	–	–	1312
2020 Q1	–	Hold	0	–	–	–	1247
2019 Q4	–	Hold	0	–	–	–	1138
2019 Q3	–	Hold	0	–	–	–	1113
2019 Q2	–	Hold	0	–	–	–	1093
2019 Q1	–	Hold	0	–	–	–	1063
2018 Q4	–	Hold	0	–	–	–	1057
2018 Q3	–	Hold	0	–	–	–	1094
2018 Q2	–	Hold	0	–	–	–	1078
2018 Q1	–	Hold	0	–	–	–	1039
2017 Q4	–	Hold	0	–	–	–	981
2017 Q3	–	Hold	0	–	–	–	964
2017 Q2	–	Hold	0	–	–	–	884
2017 Q1	–	Hold	0	–	–	–	755
2016 Q4	–	Hold	0	–	–	–	779
2016 Q3	–	Hold	0	–	–	–	783
2016 Q2	–	Hold	0	–	–	–	742

Other funds holding AIM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Verition Fund Management

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return